U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747402) titled 'Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes' on July 30.
Brief Summary: The goal of this clinical trial is to find the best way to start once-weekly insulin icodec in adults with type 2 diabetes who have not used insulin in the past 3 months, so that their fasting blood glucose reaches the target range within the first week. The main questions it aims to answer are:
* Which of three starting-dose methods brings the most people to their fasting blood glucose target by the end of the first week?
* On day 4 after starting, if fasting blood glucose is still high, does giving one extra half-dose...